ImmunityBio, Inc.
IBRXNasdaqCIK 1326110HealthcareFiscal year ends Dec 31
Reports and events: 177 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1421:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-421820 |
| 2026-08-0622:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-338651 |
| 2026-08-0411:45 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001326110-26-000079 |
| 2026-08-0411:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-26-000077 |
| 2026-07-3021:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001326110-26-000071 |
| 2026-06-1021:24 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001326110-26-000064 |
| 2026-05-1821:20 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-229153 |
| 2026-05-0711:37 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001326110-26-000059 |
| 2026-05-0711:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-26-000057 |
| 2026-04-3023:48 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001326110-26-000049 |
| 2026-04-0911:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-26-000036 |
| 2026-04-0612:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-142932 |
| 2026-03-3112:24 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-133363 |
| 2026-02-2502:51 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-072879 |
| 2026-02-2322:24 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001326110-26-000030 |
| 2026-02-2312:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-26-000025 |
| 2026-02-1814:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-26-000018 |
| 2026-01-2612:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001326110-26-000014 |
| 2026-01-1513:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-26-000008 |
| 2026-01-1413:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-26-000004 |
| 2025-12-2900:25 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-331244 |
| 2025-12-1521:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001326110-25-000146 |
| 2025-12-1212:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-25-000143 |
| 2025-11-1000:43 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-274843 |
| 2025-11-0502:53 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001326110-25-000139 |
| 2025-11-0502:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-25-000138 |
| 2025-08-0820:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-177024 |
| 2025-08-0511:36 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001326110-25-000114 |
| 2025-08-0511:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-25-000112 |
| 2025-07-2510:23 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-164789 |
| 2025-06-2020:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001326110-25-000084 |
| 2025-05-1210:46 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001326110-25-000071 |
| 2025-05-1210:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-25-000069 |
| 2025-05-0511:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-112057 |
| 2025-04-3022:22 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0001326110-25-000054 |
| 2025-04-1512:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-25-000044 |
| 2025-04-0811:45 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-075102 |
| 2025-03-1912:14 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001326110-25-000040 |
| 2025-03-0312:47 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001326110-25-000033 |
| 2025-03-0312:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-25-000031 |
| 2025-02-1302:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-025324 |
| 2025-02-0721:52 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-022776 |
| 2024-12-1112:46 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-274871 |
| 2024-12-1022:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-274438 |
| 2024-11-1913:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001326110-24-000115 |
| 2024-11-1212:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001326110-24-000111 |
| 2024-11-1212:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001326110-24-000109 |
| 2024-08-1212:03 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001326110-24-000103 |
| 2024-07-1801:48 ET | 8-K | 1.01 Entry into a material agreement | 0001326110-24-000093 |
| 2024-06-1220:36 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001326110-24-000069 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.